Granahan US Small Cap Discvs Fdrs USDAcc

Performance History31/03/2024
Growth of 1,000 (EUR)
Granahan US Small Cap Discvs Fdrs USDAcc
Fund33.911.5-29.216.66.8
+/-Cat17.0-15.2-11.73.5-2.2
+/-Idx--13.4-14.81.8-0.6
 
Key Stats
NAV
24/04/2024
 USD 15.88
Day Change 0.03%
Morningstar Category™ US Small-Cap Equity
ISIN IE00BZ3G1H34
Fund Size (Mil)
24/04/2024
 USD 1.52
Share Class Size (Mil)
24/04/2024
 USD 1.50
Max Initial Charge -
Ongoing Charge
01/01/2023
  0.87%
Investment Objective: Granahan US Small Cap Discvs Fdrs USDAcc
The investment objective of the Fund is to seek capital appreciation through investment in small, dynamic and emerging growth companies.
Returns
Trailing Returns (EUR)24/04/2024
YTD-3.57
3 Years Annualised-10.84
5 Years Annualised4.24
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Jeffrey Harrison
30/07/2021
Richard Watson
30/07/2021
Inception Date
30/06/2017
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
Russell 2000 Growth TR USDMorningstar US Sml Ext NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNo
OtherNot Specific
Portfolio Profile for  Granahan US Small Cap Discvs Fdrs USDAcc29/02/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.520.0096.52
Bonds0.000.000.00
Cash54.3852.022.36
Other1.130.001.12
Top 5 Regions%
United States95.01
United Kingdom2.62
Eurozone2.37
Canada0.00
Latin America0.00
Top 5 Sectors%
Healthcare63.75
Technology14.15
Financial Services8.55
Industrials5.40
Consumer Cyclical2.97
Top 5 HoldingsSector%
Kiniksa Pharmaceuticals Ltd Class AHealthcareHealthcare3.27
CorVel CorpFinancial ServicesFinancial Services3.01
Zymeworks Inc Registered ShsHealthcareHealthcare2.93
Shockwave Medical IncHealthcareHealthcare2.92
Syndax Pharmaceuticals IncHealthcareHealthcare2.92
Granahan US Small Cap Discvs Fdrs USDAcc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures